Shasun Chemicals technology licenses API technology to Merck

27 Feb 2008

1

Shasun Chemicals & Drugs Ltd today said that it had entered into a non-exclusive licensing agreement with Merck & Co., Inc. to allow the US drug firm the use of its proprietary cross-coupling copper technology (also known as Buchwald technology) to manufacture and commercialize active pharmaceutical ingredients (APIs).

The Buchwald cross-coupling technology is one of the most popular technologies in the pharmaceutical area allowing increasingly complex new drugs to be manufactured in an efficient and economical way.

Commenting on this development, Dr. Michel Spagnol, chief technology officer, said, " This is an important milestone for Shasun in making this technology widely accessible and paving the way for further collaborations."

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more